The Clorox Company (NYSE:CLX) Shares Purchased by Fmr LLC

FMR LLC lifted its stake in The Clorox Company (NYSE:CLX - Free Report) by 27.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 776,232 shares of the company's stock after acquiring an additional 168,111 shares during the quarter. FMR LLC owned 0.63% of Clorox worth $126,456,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in CLX. Prospera Private Wealth LLC bought a new stake in shares of Clorox in the third quarter worth approximately $27,000. Innealta Capital LLC purchased a new position in shares of Clorox in the second quarter worth $30,000. Trifecta Capital Advisors LLC lifted its holdings in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after buying an additional 130 shares in the last quarter. Family Firm Inc. bought a new stake in Clorox in the second quarter worth $31,000. Finally, Quarry LP increased its position in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after purchasing an additional 114 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.57% of the company's stock.

Clorox Stock Performance

Shares of NYSE CLX traded up $0.39 during midday trading on Wednesday, reaching $167.52. 837,488 shares of the stock were exchanged, compared to its average volume of 1,234,656. The firm has a market cap of $20.74 billion, a price-to-earnings ratio of 58.37, a PEG ratio of 3.08 and a beta of 0.42. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.35. The firm has a 50-day simple moving average of $163.27 and a two-hundred day simple moving average of $150.02. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter last year, the company earned $0.49 EPS. The business's revenue was up 27.0% on a year-over-year basis. As a group, analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. Clorox's dividend payout ratio (DPR) is 170.03%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Barclays boosted their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research report on Friday, November 1st. Evercore ISI cut their price objective on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research report on Monday, October 14th. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research report on Friday, October 11th. BNP Paribas upgraded shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. Finally, TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and boosted their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.